Suitability of Biomorphic Silicon Carbide Ceramics as Drug Delivery Systems against Bacterial Biofilms

<table>Inhibition halo profiles obtained from and <i>Staphylococcus aureus</i> culture for the treatment with different vancomycin doses 1.27 mg and 2.54 mg loaded bioSiCs.</table>

International Scholarly Research Notices

fig4

Figure 4

Figure 4: Suitability of Biomorphic Silicon Carbide Ceramics as Drug Delivery Systems against Bacterial Biofilms 